Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2017 Jul;309(5):335-347.
doi: 10.1007/s00403-017-1736-1. Epub 2017 Mar 19.

Prognostic factors for mortality in patients with bullous pemphigoid: a meta-analysis

Affiliations
Meta-Analysis

Prognostic factors for mortality in patients with bullous pemphigoid: a meta-analysis

Yi-Di Liu et al. Arch Dermatol Res. 2017 Jul.

Abstract

Bullous pemphigoid (BP) is a chronic debilitating autoimmune blistering disease that frequently occurs in the elderly population. Previous studies have suggested a high morbidity and mortality associated with BP. However, relatively few studies have investigated prognostic factors of BP mortality, and they showed considerably various results. This meta-analysis aimed to quantitatively assess the association between several potential prognostic factors and risk of mortality in bullous pemphigoid. A comprehensive search was performed using Pubmed, Embase, and Cochrane Library. Cohort studies that assessed prognostic factors of BP mortality were included. Random-effects model was utilized to calculate the pooled hazard ratio (HR). Publication bias was evaluated qualitatively by constructing a funnel plot and quantitatively by conducting Egger's test. 14 studies were included comprising 2499 patients. Combined HRs suggested that advanced age (HR 1.63, 95% CI 1.34-1.97), presence of circulating antibodies (HR 1.77, 95% CI 1.20-2.62), concomitant dementia (HR 2.01, 95% CI 1.22-3.33), and concomitant stroke (HR 1.86, 95% CI 1.29-2.67) have an unfavorable impact on patient survival. Gender, disease extent, mucosal involvement, and indirect immunofluorescence result were not shown to be linked to mortality by our analysis. This study indicated that BP patients with older age, circulating antibodies, dementia, and stroke are at greater risk of mortality. Clinicians should be aware of this association and utilize this information in patient education and treatment process.

Keywords: Autoimmune blistering disease; Bullous pemphigoid; Mortality; Prognosis; Survival.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1
Flowchart of studies included in the meta-analysis
Fig. 2
Fig. 2
Forest plots: association between bullous pemphigoid mortality and old age
Fig. 3
Fig. 3
Forest plots: association between bullous pemphigoid mortality and gender
Fig. 4
Fig. 4
Forest plots: association between bullous pemphigoid mortality and extensive disease
Fig. 5
Fig. 5
Forest plots: association between bullous pemphigoid mortality and mucosal lesion
Fig. 6
Fig. 6
Forest plots: association between bullous pemphigoid mortality and circulating BP autoantibody
Fig. 7
Fig. 7
Forest plots: association between bullous pemphigoid mortality and positive IIF
Fig. 8
Fig. 8
Forest plots: association between bullous pemphigoid mortality and dementia
Fig. 9
Fig. 9
Forest plots: association between bullous pemphigoid mortality and stroke
Fig. 10
Fig. 10
Funnel plots of studies evaluating the relationship between bullous pemphigoid mortality and potential prognostic factors a old age, b gender (male vs female), c extensive disease, d mucosal lesion, e circulating autoantibody, f positive IIF, g dementia, h stroke
Fig. 10
Fig. 10
Funnel plots of studies evaluating the relationship between bullous pemphigoid mortality and potential prognostic factors a old age, b gender (male vs female), c extensive disease, d mucosal lesion, e circulating autoantibody, f positive IIF, g dementia, h stroke

References

    1. Bernard P, Bedane C, Bonnetblanc JM. Anti-BP180 autoantibodies as a marker of poor prognosis in bullous pemphigoid: a cohort analysis of 94 elderly patients. Br J Dermatol. 1997;136:694–698. doi: 10.1111/j.1365-2133.1997.tb03654.x. - DOI - PubMed
    1. Brick KE, Weaver CH, Lohse CM, Pittelkow MR, Lehman JS, Camilleri MJ, Al-Hashimi M, Wieland CN. Incidence of bullous pemphigoid and mortality of patients with bullous pemphigoid in Olmsted County, Minnesota, 1960 through 2009. J Am Acad Dermatol. 2014;71:92–99. doi: 10.1016/j.jaad.2014.02.030. - DOI - PMC - PubMed
    1. Cai SC, Allen JC, Lim YL, Chua SH, Tan SH, Tang MB. Mortality of bullous pemphigoid in Singapore: risk factors and causes of death in 359 patients seen at the National Skin Centre. Br J Dermatol. 2014;170:1319–1326. doi: 10.1111/bjd.12806. - DOI - PubMed
    1. Colbert RL, Allen DM, Eastwood D, Fairley JA. Mortality rate of bullous pemphigoid in a US medical center. J Invest Dermatol. 2004;122:1091–1095. doi: 10.1111/j.0022-202X.2004.22504.x. - DOI - PubMed
    1. Cortés B, Khelifa E, Clivaz L, Cazzaniga S, Saurat JH, Naldi L, Borradori L. Mortality rate in bullous pemphigoid: a retrospective monocentric cohort study. Dermatology. 2012;225:320–325. doi: 10.1159/000345625. - DOI - PubMed

Publication types

LinkOut - more resources